News - Johns Hopkins, BD Diagnostics Partner for Master's Fellowship

Email to a friend

Students will work for medical technology company while earning a master’s degree in

THE JOHNS HOPKINS UNIVERSITY
OFFICE OF NEWS AND INFORMATION
901 S. Bond Street, Suite 540
Baltimore, MD 21231
Phone: (443) 287-9960 / Fax: (443) 287-9920

June 1, 2009
FOR IMMEDIATE RELEASE
Media Contact: Ken Schappelle
(202) 452-1910
kschappelle@jhu.edu

The Johns Hopkins University (JHU) and BD Diagnostics (BD) have partnered to offer a unique master’s fellowship in the field of bioscience regulatory affairs. Prospective fellows should apply now for the fall 2009 semester.

“Johns Hopkins and BD Diagnostics have a shared interest in cultivating and educating the next generation of workers in the field of regulatory affairs,” said Dr. Lynn Johnson Langer, associate program chair of Johns Hopkins’ master of science in bioscience regulatory affairs program.

Students accepted into this fellowship will take bioscience regulatory affairs courses at Johns Hopkins’ Montgomery County Campus in Rockville, Md., the Homewood campus in Baltimore, Md., or online.

“We see this as an opportunity to employ and mentor some of the best talent in the industry,” said Marc Rize, human resources director. “The rigor of Johns Hopkins’ master of science in bioscience regulatory affairs curriculum, combined with real world application and mentoring from seasoned professionals at BD, will create a world-class experience for a select group of up-and-coming regulatory affairs students.”

Selected students will be employed by BD and will, therefore, be required to successfully complete BD’s employment process and meet BD’s requirements for continued employment. . During the initial five-year phase of this fellowship, BD will provide salary and tuition support for up to five incoming JHU students each year. BD will also provide, through designated members of its staff mentoring of JHU fellowship students.

About JHU’s MS in Bioscience Regulatory Affairs Program
Students in the MS in Bioscience Regulatory Affairs Program take six required regulatory courses. With this foundation, students will have the opportunity to specialize in an aspect of regulatory affairs of their choice through three elective courses, including advanced regulatory, business, and science courses.

Finally, hands-on, real life experience will be provided to students through a practicum course at the end of the program. The strong science foundation, the opportunity to specialize, and the practicum requirement distinguish this program as a leader in bioscience regulatory affairs education. Students completing the program are expected to be able to lead regulatory affairs initiatives in government and industry. For more information, please visit www.regulatory.jhu.edu.

About BD Diagnostics
BD (NYSE: BDX) is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people's health throughout the world. BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 28,000 people in approximately 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. For more information, please visit www.bd.com.

Share this:

Subscribe to Advanced Academic Programs News and Events:

<< Back to Previous Page